Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2010-12-03 12:00:00
Reporting Period:
Filing Date:
Accepted Time:
2010-12-03 17:41:04
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1339455 Somaxon Pharmaceuticals Inc. SOMX Pharmaceutical Preparations (2834) 200161599
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380762 Brian Dorsey C/o Somaxon Pharmaceuticals, Inc.
3570 Carmel Mountain Road, Suite 100
San Diego CA 92130
Svp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-01 8,468 $2.68 43,452 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, with the proceeds remitted to the Company to cover the taxes withheld upon the vesting of 22,500 restricted stock units on December 1, 2010.
  2. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $2.62 to $2.79 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.